Evidence map›Paper›PMID 38248418›Full record

ArticleBiosensors2024

Understanding DNA Epigenetics by Means of Raman/SERS Analysis for Cancer Detection.

Luca David, Anca Onaciu, Valentin Toma, Rareș-Mario Borșa, Cristian Moldovan, Adrian-Bogdan Țigu, Diana Cenariu, Ioan Șimon, Gabriela-Fabiola Știufiuc, Eugen Carasevici and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
6.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Luca DavidFaculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Anca OnaciuMedFuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Valentin TomaMedFuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-8322-1180
Rareș-Mario BorșaMedFuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.ORCID 0009-0007-1754-2681
Cristian MoldovanMedFuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Adrian-Bogdan ȚiguMedFuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-9397-0791
Diana CenariuMedFuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Ioan ȘimonDepartment of Surgery, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Gabriela-Fabiola ȘtiufiucFaculty of Physics, "Babes Bolyai" University, 400084 Cluj-Napoca, Romania.
Eugen CaraseviciNanotechnology Laboratory, TRANSCEND Research Center, Regional Institute of Oncology, 700483 Iasi, Romania.ORCID 0000-0002-2808-7019
Brîndușa DrăgoiNanotechnology Laboratory, TRANSCEND Research Center, Regional Institute of Oncology, 700483 Iasi, Romania.
Ciprian TomuleasaMedFuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-5500-1519
Rareș-Ionuț ȘtiufiucMedFuture-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.ORCID 0000-0001-6769-1545
Iuliu Hațieganu University of Medicine and Pharmacy · ROInstitutul Regional de Oncologie · ROBabeș-Bolyai University · RO

Funding

"Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania 35/172/17.12.2021
6 · The paper itself

Abstract

This study delves into the intricate interaction between DNA and nanosystems, exploring its potential implications for biomedical applications. The focus lies in understanding the adsorption geometry of DNA when in proximity to plasmonic nanoparticles, utilizing ultrasensitive vibrational spectroscopy techniques. Employing a combined Raman-SERS analysis, we conducted an in-depth examination to clarify the molecular geometry of interactions between DNA and silver nanoparticles. Our findings also reveal distinctive spectral features regarding DNA samples due to their distinctive genome stability. To understand the subtle differences occurring between normal and cancerous DNA, their thermal stability was investigated by means of SERS measurement performed before and after a thermal treatment at 94 °C. It was proved that thermal treatment did not affect DNA integrity in the case of normal cells. On the other hand, due to epimutation pattern that characterizes cancerous DNA, variations between spectra recorded before and after heat treatment were observed, suggesting genome instability. These findings highlight the potential of DNA analysis using SERS for cancer detection. They demonstrate the applicability of this approach to overcoming challenges associated with low DNA concentrations (e.g., circulating tumor DNA) that occur in biofluids. In conclusion, this research contributes significant insights into the nanoscale behavior of DNA in the presence of nanosystems.

Indexed as

Metal NanoparticlesNeoplasmsAdsorptionDNAEpigenesis, GeneticSilverDNASilverDNAepigeneticsmultiple myelomaplasmonic substratesRaman-SERS spectroscopy

Identifiers

PMID38248418
PMCPMC10813173
OpenAlexW4390816902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.